| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 222.17 | 3.2% | 7.8% |
| Total Income | 225.12 | 1.7% | 4.8% |
| Expenditure | 184.70 | 4.8% | 8.3% |
| PBT | 40.42 | 23.5% | 8.8% |
| Net Profit | 31.08 | 21.0% | 5.4% |
| OPM | 19.51% | 1.39pp | 0.08pp |
| NPM | 13.81% | 3.38pp | 1.49pp |
| EPS | 39.21 | 21.0% | 5.4% |
Elantas Beck India: Net Profit at ₹3,108.43 Lakhs for Q4 FY26
12 May 2026 · 12 May, 7:22 pm
Summary
ELANTAS Beck India Limited announced its unaudited financial results for the quarter ended March 31, 2026, demonstrating a mixed performance. Revenue from operations for Q4 FY26 grew by 7.78% year-on-year to ₹222.17 crore, alongside a sequential growth of 3.24%. However, the company's net profit saw a decline of 5.43% year-on-year to ₹31.08 crore and a more substantial quarter-on-quarter drop of 21.04%. EBITDA for the quarter was ₹46.31 crore, achieving a margin of 20.84%. Management expects a positive outcome regarding the permanent revocation of the Ankleshwar facility's closure order, which is currently extended temporarily until October 2026.
Key Highlights
- 1
ELANTAS Beck India Limited reported revenue from operations of ₹222.17 crore for the quarter ended March 31, 2026, marking a 7.78% increase year-on-year from ₹206.13 crore in the corresponding prior quarter.
- 2
Net Profit for Q4 FY26 stood at ₹31.08 crore, which is a decrease of 5.43% compared to ₹32.87 crore in the same quarter last year.
- 3
Earnings per share (Basic and Diluted) for the quarter ended March 31, 2026, was ₹39.21.
- 4
The company's EBITDA for the quarter was ₹46.31 crore, corresponding to an EBITDA margin of 20.84%.
- 5
On a sequential basis, revenue from operations grew by 3.24%, while net profit declined significantly by 21.04%.
- 6
The company's Ankleshwar facility continues operations under a temporary revocation of the closure order until October 3, 2026, with management expressing confidence in securing a permanent revocation.
Informational and educational content only. Not investment advice.